Cargando…

A Novel Serum Metabolomic Profile for the Differential Diagnosis of Distal Cholangiocarcinoma and Pancreatic Ductal Adenocarcinoma

The diagnosis of adenocarcinomas located in the pancreas head, i.e., distal cholangiocarcinoma (dCCA) and pancreatic ductal adenocarcinoma (PDAC), constitutes a clinical challenge because they share many symptoms, are not easily distinguishable using imaging techniques and accurate biomarkers are no...

Descripción completa

Detalles Bibliográficos
Autores principales:	Macias, Rocio I.R., Muñoz-Bellvís, Luis, Sánchez-Martín, Anabel, Arretxe, Enara, Martínez-Arranz, Ibon, Lapitz, Ainhoa, Gutiérrez, M. Laura, La Casta, Adelaida, Alonso, Cristina, González, Luis M., Avila, Matias A., Martinez-Chantar, Maria L., Castro, Rui E., Bujanda, Luis, Banales, Jesus M., Marin, Jose J.G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352809/ https://www.ncbi.nlm.nih.gov/pubmed/32486461 http://dx.doi.org/10.3390/cancers12061433

Ejemplares similares

Serum Metabolites as Diagnostic Biomarkers for Cholangiocarcinoma, Hepatocellular Carcinoma, and Primary Sclerosing Cholangitis
por: Banales, Jesus M., et al.
Publicado: (2019)

Extracellular Vesicles in Hepatobiliary Malignancies
por: Lapitz, Ainhoa, et al.
Publicado: (2018)

Patients with Cholangiocarcinoma Present Specific RNA Profiles in Serum and Urine Extracellular Vesicles Mirroring the Tumor Expression: Novel Liquid Biopsy Biomarkers for Disease Diagnosis
por: Lapitz, Ainhoa, et al.
Publicado: (2020)

Liquid biopsy-based protein biomarkers for risk prediction, early diagnosis, and prognostication of cholangiocarcinoma
por: Lapitz, Ainhoa, et al.
Publicado: (2023)

Liver Metastases of Intrahepatic Cholangiocarcinoma: Implications for an Updated Staging System
por: Lamarca, Angela, et al.
Publicado: (2021)

Genomic Heterogeneity of Pancreatic Ductal Adenocarcinoma and Its Clinical Impact
por: Gutiérrez, María Laura, et al.
Publicado: (2021)

Cholangiocarcinoma progression depends on the uptake and metabolization of extracellular lipids
por: Ruiz de Gauna, Mikel, et al.
Publicado: (2022)

Extracellular Vesicles in NAFLD/ALD: From Pathobiology to Therapy
por: Hernández, Alejandra, et al.
Publicado: (2020)

Profiling of promoter occupancy by the SND1 transcriptional coactivator identifies downstream glycerolipid metabolic genes involved in TNFα response in human hepatoma cells
por: Arretxe, Enara, et al.
Publicado: (2015)

Detection of circulating tumor cells in blood of pancreatic ductal adenocarcinoma patients
por: Mayado, Andrea, et al.
Publicado: (2020)

The promoter of cell growth- and RNA protection-associated SND1 gene is activated by endoplasmic reticulum stress in human hepatoma cells
por: Armengol, Sandra, et al.
Publicado: (2014)

RIPK3 acts as a lipid metabolism regulator contributing to inflammation and carcinogenesis in non-alcoholic fatty liver disease
por: Afonso, Marta B, et al.
Publicado: (2021)

Plasma Membrane Transporters as Biomarkers and Molecular Targets in Cholangiocarcinoma
por: Marin, Jose J.G., et al.
Publicado: (2020)

Adiponectin, Leptin, and IGF-1 Are Useful Diagnostic and Stratification Biomarkers of NAFLD
por: Marques, Vanda, et al.
Publicado: (2021)

Effect of pravastatin on the survival of patients with advanced gastric cancer
por: Bujanda, Luis, et al.
Publicado: (2015)

SREBP-2-driven transcriptional activation of human SND1 oncogene
por: Armengol, Sandra, et al.
Publicado: (2017)

Next-Generation Biomarkers for Cholangiocarcinoma
por: Rodrigues, Pedro M., et al.
Publicado: (2021)

Impact of Positive Lymph Nodes and Resection Margin Status on the Overall Survival of Patients with Resected Perihilar Cholangiocarcinoma: The ENSCCA Registry
por: Nooijen, Lynn E., et al.
Publicado: (2022)

Heterogeneity of Cholangiocarcinoma Immune Biology
por: Vita, Francesca, et al.
Publicado: (2023)

Hepatocellular Carcinoma: Updates in Pathogenesis, Detection and Treatment
por: Martínez-Chantar, Maria L., et al.
Publicado: (2020)

Identification and characterization of the gene expression profiles for protein coding and non-coding RNAs of pancreatic ductal adenocarcinomas
por: Gutiérrez, María Laura, et al.
Publicado: (2015)

Targeted UPLC-MS Metabolic Analysis of Human Faeces Reveals Novel Low-Invasive Candidate Markers for Colorectal Cancer
por: Cubiella, Joaquin, et al.
Publicado: (2018)

Inhibition of NAE‐dependent protein hyper‐NEDDylation in cystic cholangiocytes halts cystogenesis in experimental models of polycystic liver disease
por: Lee‐Law, Pui Y., et al.
Publicado: (2021)

Pharmacogenetics of hepatocellular carcinoma and cholangiocarcinoma
por: Alonso-Peña, Marta, et al.
Publicado: (2019)

Association between Genetic Subgroups of Pancreatic Ductal Adenocarcinoma Defined by High Density 500 K SNP-Arrays and Tumor Histopathology
por: Gutiérrez, María Laura, et al.
Publicado: (2011)

Unclassified Diffuse Ductal Cholangiocarcinoma; Report of a Case
por: Aydın, Ünal, et al.
Publicado: (2014)

Intrahepatic cholangiocarcinoma with predominant ductal plate malformation pattern
por: Choe, Ji-Young, et al.
Publicado: (2014)

Adjuvant chemoradiotherapy for positive hepatic ductal margin on cholangiocarcinoma
por: Sugiura, Teiichi, et al.
Publicado: (2020)

The altered serum lipidome and its diagnostic potential for Non-Alcoholic Fatty Liver (NAFL)-associated hepatocellular carcinoma
por: Lewinska, Monika, et al.
Publicado: (2021)

Role of drug transporters in the sensitivity of acute myeloid leukemia to sorafenib
por: Macias, Rocio I.R., et al.
Publicado: (2018)

Donor risk factors in pancreas transplantation
por: Muñoz-Bellvís, Luis, et al.
Publicado: (2020)

Pravastatin inhibits cell proliferation and increased MAT1A expression in hepatocarcinoma cells and in vivo models
por: Hijona, Elizabeth, et al.
Publicado: (2012)

Setup of multidisciplinary team discussions for patients with cholangiocarcinoma: current practice and recommendations from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)
por: Casadio, M., et al.
Publicado: (2022)

Magnesium, Little Known But Possibly Relevant: A Link between NASH and Related Comorbidities
por: Simón, Jorge, et al.
Publicado: (2021)

N-Cadherin Distinguishes Intrahepatic Cholangiocarcinoma from Liver Metastases of Ductal Adenocarcinoma of the Pancreas
por: Gerber, Tiemo S., et al.
Publicado: (2022)

Surgical management of carcinoma in situ at ductal resection margins in patients with extrahepatic cholangiocarcinoma
por: Wakai, Toshifumi, et al.
Publicado: (2018)

Thrombospondin-2 as a diagnostic biomarker for distal cholangiocarcinoma and pancreatic ductal adenocarcinoma
por: Byrling, J., et al.
Publicado: (2021)

Genetic, Clinicopathological, and Radiological Features of Intrahepatic Cholangiocarcinoma with Ductal Plate Malformation Pattern
por: Chung, Taek, et al.
Publicado: (2022)

Vascular Resection in Perihilar Cholangiocarcinoma
por: Serrablo, Alejandro, et al.
Publicado: (2021)

Mitogen-Activated Protein Kinases (MAPKs) and Cholangiocarcinoma: The Missing Link
por: Chen, Chaobo, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_2iptn2k1obsvcnoju4h0vnvrmi